抄録
Ulinastatin (urinary trypsin inhibitor) and α1-microglobulin levels in urine samples of 39 dementia patients (Alzheimer-type dementia, 21 cases; vascular dementia, 18 cases) and 14 normal subjects were measured. There was a positive correlation between the ulinastatin and α1-microglobulin levels. Lower scores on the dementia rating scale and activities of daily living were observed in patients with Alzheimer-type dementia but not with vascular dementia, where a lower α1-microglobulin level was registered. However, the ulinastatin level did not correlate with the scores in patients with either Alzheimer-type or vascular dementia. These results indicate that the urinary ar-microglobulin level provides a useful biochemical index of the severity of Alzheimer-type dementia.